My research interests include the treatment of Autoimmune Hepatitis, Primary Sclerosing Cholangitis and Primary Biliary Cholangitis
Publications
Yan K, Forman L. Cannabinoid Use Among Liver Transplant Recipients. Liver Transpl. 2021 Nov;27(11):1623-1632. PubMed PMID: 34018308
Francis P, Forman L. HATs Off to Clot Blockers: A Potential New Role for Statins After Transplantation. Liver Transpl. 2021 Oct;27(10):1375-1377. PubMed PMID: 34118130
Cristin DJ, Forman LM, Jackson WE.Beyond survival: Targeting health-related quality of life outcomes after liver transplant. Clin Liver Dis 2021;17:359-64.
Francis P, Forman L. Statins show promise against progression of liver disease. Liver Transpl 2021;18:280-7
Frances P, Forman L. Use of statins in patients with and without liver disease. Clin Liv Dis 2020;15(1):40-45
Bowlus CL, Pockros PJ et al. Long term obeticholic acid therapy improves histology in patients with primary biliary cholangitis. Clin Gastroenterol Hepatol 2020;28(5):1170-1178
Francis P, Forman L. Use of Statins in Patients With and Without Liver Disease. Clin Liver Dis (Hoboken). 2020 Jan;15(1):40-45. PubMed PMID: 32104577
Bowlus CL, Pockros PJ, Kremer AE, Parés A, Forman LM, Drenth JPH, Ryder SD, Terracciano L, Jin Y, Liberman A, Pencek R, Iloeje U, MacConell L, Bedossa P. Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2020 May;18(5):1170-1178.e6. PubMed PMID: 31606455
Leehey MA, Liu Y, Hart F, Epstein C, Cook M, Sillau S, Klawitter J, Newman H, Sempio C, Forman L, Seeberger L, Klepitskaya O, Baud Z, Bainbridge J. Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study. Cannabis Cannabinoid Res. 2020;5(4):326-336. PubMed PMID: 33381646